Chai, Da-Min <br/><br/>
WISP2 exhibits its potential antitumor activity via targeting ERK and E-cadherin pathways in esophageal cancer cells.  [electronic resource] 

 -  Journal of experimental & clinical cancer research : CR  Feb 2019 
 - 102 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1756-9966 
<br/><br/><label>Standard No.: </label>10.1186/s13046-019-1108-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Animals<br/>Antigens, CD--metabolism<br/>Biomarkers, Tumor--analysis<br/>CCN Intercellular Signaling Proteins--metabolism<br/>Cadherins--metabolism<br/>Cell Line, Tumor<br/>Cell Movement--physiology<br/>Cell Proliferation--physiology<br/>Disease-Free Survival<br/>Esophageal Neoplasms--metabolism<br/>Esophageal Squamous Cell Carcinoma--metabolism<br/>Female<br/>Heterografts<br/>Humans<br/>MAP Kinase Signaling System--physiology<br/>Male<br/>Mice<br/>Mice, Nude<br/>Middle Aged<br/>Prognosis<br/>Repressor Proteins--metabolism